Merck
CN
  • Saturated fat-rich diet increases fetal lipids and modulates LPL and leptin receptor expression in rat placentas.

Saturated fat-rich diet increases fetal lipids and modulates LPL and leptin receptor expression in rat placentas.

The Journal of endocrinology (2013-03-14)
M B Mazzucco, R Higa, E Capobianco, M Kurtz, A Jawerbaum, V White
摘要

Metabolic alterations in obese and overweight mothers impact the placenta and the fetus, leading to anomalies in fetal growth and lipid accretion. The primary aim of the study was to examine the effect of a saturated fat-rich diet (FD) on growth, lipid accretion, and lipases, leptin and leptin receptor (ObR) expression in the placenta and fetal liver. We also aimed to find a role for fetal leptin in the modulation of placental and fetal liver lipase and ObR expression. Six-week-old rats were fed with a standard rat chow (control) or a 25% FD for 7 weeks until mating and during pregnancy. Also, in a group of control rats, fetuses were injected with leptin on days 19, 20, and 21 of pregnancy. On day 21, we assessed lipidemia, insulinemia, and leptinemia in mothers and fetuses. In the placenta and fetal liver, lipid concentration was assessed by thin layer chromatography (TLC) and the gene expression of lipoprotein lipase (LPL), endothelial lipase, insulin receptor (Insr), leptin, and ObR by RT-PCR. The FD induced hypertriglyceridemia and hyperleptinemia (P<0.01) in mothers and fetuses, an increase in maternal (P<0.05) and fetal weight (P<0.01), overaccumulation of lipids in fetal liver (P<0.01), and enhanced leptin expression in the placenta and fetal liver (P<0.05). Placental expression of IR and LPL was increased (P<0.05), and ObR decreased (P<0.05) in the FD group. Fetal administration of leptin induced the placental and fetal liver downregulation of ObR (P<0.05) and upregulation of LPL expression (P<0.05). The FD led to increased fetal lipid levels, which may result from high maternal lipid availability and fetal leptin effects.

材料
货号
品牌
产品描述

Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, Type VII, ≥700 unit/mg solid
Sigma-Aldrich
脂肪酶 来源于猪胰腺, Type II, ≥125 units/mg protein (using olive oil (30 min incubation)), 30-90 units/mg protein (using triacetin)
Sigma-Aldrich
脂肪酶丙烯酸树脂, ≥5,000 U/g, recombinant, expressed in Aspergillus niger
Sigma-Aldrich
重组脂肪酶 B 南极假丝酵母 来源于米曲霉, powder, beige, ~9 U/mg
Sigma-Aldrich
脂肪酶 来源于猪胰腺, Type VI-S, ≥20,000 units/mg protein, lyophilized powder
Sigma-Aldrich
脂肪酶 来源于米曲霉, solution, ≥100,000 U/g, white, beige
Sigma-Aldrich
脂蛋白脂肪酶 来源于假单胞菌 属, lyophilized, powder, ≥1200 U/mg
Sigma-Aldrich
脂肪酶 来源于黑曲霉, powder (fine), ~200 U/g
Sigma-Aldrich
脂肪酶 来源于洋葱假单胞菌, powder, light beige, ≥30 U/mg
Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, lyophilized powder, ≥40,000 units/mg protein
Sigma-Aldrich
脂肪酶 来源于念珠菌 属, recombinant, expressed in Aspergillus niger
Sigma-Aldrich
脂肪酶 来源于小麦胚芽, Type I, lyophilized powder, 5-15 units/mg solid
Sigma-Aldrich
固定化脂肪酶 来源于南极假丝酵母, beads, slightly brown, >2 U/mg
Sigma-Aldrich
脂蛋白脂酶 来源于伯克霍尔德氏菌 属, lyophilized powder, ≥50,000 units/mg solid
Sigma-Aldrich
脂肪酶 来源于米根霉, powder (fine), ~10 U/mg
Sigma-Aldrich
脂肪酶 来源于米赫根毛霉, ≥20,000 U/g
Sigma-Aldrich
脂肪酶 来源于假单胞菌 属, Type XIII, lyophilized powder, ≥15 units/mg solid
Sigma-Aldrich
脂肪酶 来源于米黑毛霉菌, powder, slightly brown, ~1 U/mg
Sigma-Aldrich
脂肪酶 来源于米曲霉, lyophilized, powder, white, ~50 U/mg
Sigma-Aldrich
南极假丝酵母脂肪酶A,重组 来源于米曲霉, powder, beige, ~2 U/mg
Sigma-Aldrich
脂蛋白脂酶 来源于牛奶, ammonium sulfate suspension, ≥2,000 units/mg protein (BCA)
Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, powder, yellow-brown, ≥2 U/mg
Sigma-Aldrich
脂肪酶 来源于皱褶假丝酵母, lyophilized, powder (fine), 15-25 U/mg
Sigma-Aldrich
脂肪酶 来源于猪胰腺 来源于雪白根霉菌, powder (fine), ≥1.5 U/mg
Sigma-Aldrich
脂肪酶 来源于米黑毛霉菌, lyophilized powder, ≥4,000 units/mg solid (using olive oil)
Sigma-Aldrich
脂肪酶 来源于爪哇毛霉菌, lyophilized powder, ≥300 units/mg solid (using olive oil)
Sigma-Aldrich
脂蛋白脂肪酶 来源于假单胞菌 属, lyophilized, powder, yellow-brown, ≥160 U/mg